Amanote Research

Amanote Research

    RegisterSign In

Targeting the HER Family With Pan-Her Effectively Overcomes Resistance to Cetuximab

European Journal of Cancer - United Kingdom
doi 10.1016/s0959-8049(16)32810-6
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

December 1, 2016

Authors
M. IidaH. BahrarT. BrandH. PearsonJ. CoanR. OrbuchB. FlaniganA. SwickP. PrabakaranJ. LanttoI. HorakM. KraghR. SalgiaR. KimpleD. Wheeler
Publisher

Elsevier BV


Related search

A HER 1-2 Punch: Dual EGFR Targeting Deals Resistance a Deadly Blow

Cancer Discovery
Oncology
2014English

HER-3 Targeting Alters the Dimerization Pattern of ErbB Protein Family Members in Breast Carcinomas

Oncotarget
Oncology
2015English

To(get)her

English

Quebec and Her Sisters in the Third Legal Family

Conférence wainwright
2009English

Dual Kinase Inhibition of EGFR and HER2 Overcomes Resistance to Cetuximab in a Novel in Vivo Model of Acquired Cetuximab Resistance

Clinical Cancer Research
Cancer ResearchOncology
2011English

Draw(her)

Atlantis: Critical Studies in Gender, Culture & Social Justice
2019English

Granadas: Katherine to Her Daughter

2015English

Her Resume Says Pipelines. Her Card Says IBM.

Chemical and Engineering News
Chemical Engineering
1999English

A House Divided: Mary Todd Lincoln and Her Family

Reviews in American History
MedicineHistory
1988English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy